Efficacy of Cognitive Behavioural Therapy for Insomnia and Bright Light Therapy in Adolescents With ADHD, Insomnia, and Evening Chronotype

NCT ID
NCT07767617
Registry status
Not yet recruiting
Study type
Interventional
Phase
Not applicable
Sponsor
The University of Hong Kong
Conditions
ADHD, Chronotype, Eveningness, Insomnia, Treatment Effectiveness

Overview

ClinicalTrials.gov lists this study as Not yet recruiting.

Official title: Efficacy of Cognitive Behavioural Therapy for Insomnia and Bright Light Therapy in Adolescents With ADHD and Comorbid Insomnia and Evening Chronotype: A Randomised, Assessor Blind, Parallel-group Trial

Enrollment: 150 participants (Estimated).

What is being studied

  • Behavioral: CBT-I with Bright Light Group
  • Behavioral: CBT-I with Placebo Light Group

Who may be eligible

Ages
10 Years to 24 Years
Sex
All
Healthy volunteers accepted
No

ClinicalTrials.gov lists the following eligibility criteria.

Inclusion criteria: An adolescent who meets the following criteria will be eligible for taking part in this study: 1. aged 10-24 years old; 2. ADHD diagnosis confirmed by DISC-IV; 3. DSM-5 diagnosis of insomnia disorder with an ≥ 9 (suggested cut-off for adolescents); 4. Being classified as evening chronotype according to the score on the Horne-Östberg Morning-Eveningness Questionnaire (MEQ) and having a sleep onset time of 11:15pm or later for 12 year olds, 11:30pm or later for 13-14 year olds, 12:00am or later for 15-17 years old \[64\], 10:56pm or later for 18-24 years old at least 3 nights per week in the past 3 months and as confirmed by a 7-day sleep diary; 5. Written informed consent from the participant and their parent/guardian (for those aged under 18); 6. Being able to comply with the study protocol; 7. Either not on ADHD medication or stabilized on medications for at least 6 months. Exclusion criteria: An adolescent who meets one or more of the following criteria will be excluded from the study: 1. Substance abuse or dependence; a current or past history of manic or hypomanic episode, schizophrenia, ASD, organic mental disorders, or intellectual disabilities; 2. Prominent medical condition affecting sleep (e.g., severe eczema, GERD); 3. Clinically diagnosed sleep disorder other than insomnia disorder, such as narcolepsy, sleep-disordered breathing, and restless leg syndrome; 4. Concurrent, regular use of medications(s) known to affect sleep continuity and quality including both prescribed medications (e.g., hypnotics, steroids) and over-the-counter OTC medications (e.g., melatonin, Traditional Chinese Medicine, TCM), except for ADHD stimulants; 5. Ongoing psychological treatment for sleep problems; 6. With hearing or speech deficit; 7. Having a clinically significant suicidality (presence of suicidal ideation with a plan or an attempt).

Study locations

1 study location is listed.

Site recruitment status is not specified in the registry data for these locations.

Countries: Hong Kong

Sample of listed locations

  • Sleep Research Clinic & Laboratory, Department of Psychology, The University of Hong Kong, Hong Kong, — Hong Kong, Hong Kong — Site recruitment status not specified in the registry data

Study details

Start date
August 10, 2026
Primary completion date
August 31, 2029
Completion date
August 31, 2029
First posted
August 17, 2026
Collaborators
Chinese University of Hong Kong, Education University of Hong Kong, The Hong Kong Polytechnic University

Source and update information

Source
ClinicalTrials.gov
NCT ID
NCT07767617
Registry last updated
August 24, 2026
QualifiedStudies registry data refreshed
September 28, 2026
QualifiedStudies record fetched
September 28, 2026

View NCT07767617 on ClinicalTrials.gov

Trial information can change. Confirm current study details with the study team or the registry.

About joining clinical research

Find clinical trials you may match with

QualifiedStudies can help you search for research opportunities related to your health. Availability of this specific study through QualifiedStudies has not been established.

Find clinical trials you may match with | ADHD studies | Clinical trial FAQ